Nautilus Biotechnology, Inc. (NAUT): Total Assets

Annual figures by period end, from SEC filings.

$191.11M
As of 2025-12-31
$163.58M
As of 2026-06-30
-18.3%
3-year compound annual growth
+17.6%
5-year compound annual growth
$398.45M2020-12-31: $85.01M2021-12-31: $398.45M2022-12-31: $350.05M2023-12-31: $305.56M2024-12-31: $242.74M2025-12-31: $191.11M$191.11M
2020-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$191.11M-21.3%2026-02-26, Balance as of period end
2024-12-31$242.74M-20.6%2026-02-26, Balance as of period end
2023-12-31$305.56M-12.7%2025-02-27, Balance as of period end
2022-12-31$350.05M-12.1%2024-02-28, Balance as of period end
2021-12-31$398.45M+368.7%2023-02-23, Balance as of period end
2020-12-31$85.01Mn/a2022-02-24, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Nautilus Biotechnology, Inc. (NAUT)2025-12-31$191.11M-21.3%
908 Devices Inc. (MASS)2025-12-31$190.07M+19.2%
Seer, Inc. (SEER)2025-12-31$296.08M-19.2%
EyePoint, Inc. (EYPT)2025-12-31$364.00M-13.0%
Quanterix Corp (QTRX)2025-12-31$418.77M+3.0%
Harvard Bioscience Inc (HBIO)2025-12-31$80.07M-36.8%
Cytek Biosciences, Inc. (CTKB)2025-12-31$461.54M-7.6%
Rapid Micro Biosystems, Inc. (RPID)2025-12-31$74.85M-23.8%
Bionano Genomics, Inc. (BNGO)2025-12-31$73.58M-4.0%

Compare NAUT, MASS, SEER, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗